EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey

Nicolas Benech iD, Nadim Cassir, Laurent Alric, Frédéric Barbut, Rui Batista, Alexandre Bleibtreu, Thomas Briot, Benjamin Davido, Tatiana Galperine, Anne-Christine Joly, Nathalie Kapel, Chloé Melchior iD und 8 weitere

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.18330 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Nicolas Benech und 19 weiteren Autor:innen. Beteiligte Einrichtung: French Faecal Transplant Group (GFTF), France. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Clostridium Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Detailed comparative assessment of procedure‐related factors associated with faecal microbiota transplantation (FMT) efficacy in Clostridioides difficile infection (CDI) is limited.

Aims

We took advantage of the differences in procedures at the various French FMT centres to determine clinical and procedure‐related factors associated with FMT success in CDI.

Methods

We performed a nationwide retrospective multicentre cohort study. All FMTs performed within The French Faecal Transplant Group for CDI from 2018 to 2022 were included. Clinical data were collected retrospectively from recipient medical files, characteristics of stool transplant preparations were prospectively collected by each Pharmacy involved. Univariate and multivariate analyses were performed using Fisher's test and multiple logistic regression.

Results

Six hundred fifty‐eight FMTs were performed for 617 patients in 17 centres. The overall efficacy of FMT was 84.3% (520/617), with 0.5% of severe adverse events possibly related to FMT (3/658). Forty‐seven patients were treated at the first recurrence of CDI with a similar success rate (85.1%). Severe chronic kidney disease (CKD; OR: 2.18, 95%CI [1.20–3.88]), non‐severe refractory CDI (OR: 15.35, [1.94–318.2]), the use of ≥ 80% glycerol (OR: 2.52, [1.11–5.67]), insufficient bowel cleansing (OR: 5.47, [1.57–20.03]) and partial FMT retention (OR: 9.97, [2.62–48.49]) were associated with CDI recurrence within 8 weeks.

Conclusions

Conditions of transplant manufacturing, bowel cleansing, and a route of delivery tailored to the patient's characteristics are key factors in optimising FMT efficacy. FMT at first recurrence showed high success in real‐life practice, whereas it had lower efficacy in severe CDI and non‐severe refractory CDI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fecal Microbiota TransplantationClostridium InfectionsHumansFranceMaleFemaleRetrospective StudiesAgedMiddle AgedTreatment OutcomeRecurrenceClostridioides difficileAdultAged, 80 and overSurveys and Questionnaires

Stichwörter der Autor:innen

Clostridioides difficile infectionfaecal microbiota transplantationfrozen preparationglycerol

Autor:innen und Institutionen

  • French Faecal Transplant Group (GFTF), France.
  • Hepato-Gastroenterology Department, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
  • Lyon GEM Microbiota Study Group, Lyon, France.
  • ESGHAMI (ESCMID Study Group for Host and Microbiota Interactions), Basel, Switzerland.
  • Claude Bernard Lyon 1 University, CRCL, Lyon, France.
  • ESGCD (ESCMID Study Group for Clostridioides difficile), Basel, Switzerland.

ORCID-Profile: Nicolas Benech, Chloé Melchior, Bénédicte Pigneur, Harry Sokol

Zitieren

APA

Benech, N., Cassir, N., Alric, L., Barbut, F., Batista, R., Bleibtreu, A., Briot, T., Davido, B., Galperine, T., Joly, A. C., Kapel, N., Melchior, C., Mosca, A., Nebbad, B., Pigneur, B., Schneider, S. M., Wasiak, M., Scanzi, J., Sokol, H., & French Faecal Transplant Group (GFTF) (2025). Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18330

Vancouver

Benech N, Cassir N, Alric L, Barbut F, Batista R, Bleibtreu A, et al. Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.18330

BibTeX
@article{Benech2025,
  author = {Benech, Nicolas and Cassir, Nadim and Alric, Laurent and Barbut, Frédéric and Batista, Rui and Bleibtreu, Alexandre and Briot, Thomas and Davido, Benjamin and Galperine, Tatiana and Joly, Anne-Christine and Kapel, Nathalie and Melchior, Chloé and Mosca, Alexis and Nebbad, Biba and Pigneur, Bénédicte and Schneider, Stéphane M and Wasiak, Mathieu and Scanzi, Julien and Sokol, Harry and French Faecal Transplant Group (GFTF), French Faecal Transplant Group (GFTF)},
  title = {Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.18330}
}
Kostenlos starten →